Abstract
BackgroundAutoantigen-specific immunotherapy by mucosal tolerance induction via the intranasal route is an attractive therapeutic option for the treatment of autoimmune diseases, including rheumatoid arthritis (RA). Human cartilage glycoprotein-39 (HC gp-39)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have